Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 68,370 shares at $27.82 ($2.0M) on 2018-09-06, disclosed to the SEC on 2018-09-06.
Open-market sale of $2.0M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.41 | 20,256 | $596K | 30.3% |
| 2 | $29.41 | 20,256 | $596K | 30.3% |
| 3 | $29.00 | 200 | $6K | 0.3% |
| 4 | $27.82 | 13,829 | $385K | 19.6% |
| 5 | $27.82 | 13,829 | $385K | 19.6% |
| Total | $28.77 avg | 68,370 |
| $2.0M |
| 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |